GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List

BioShares Biotechnology Clinical Trials ETF Price (Quote)

$24.71
-0.770 (-3.02%)
At Close: Apr 19, 2024

Range Low Price High Price Comment
30 days $24.57 $29.63 Friday, 19th Apr 2024 BBC stock ended at $24.71. This is 3.02% less than the trading day before Thursday, 18th Apr 2024. During the day the stock fluctuated 4.15% from a day low at $24.57 to a day high of $25.59.
90 days $24.09 $31.99
52 weeks $16.88 $31.99

Historical BioShares Biotechnology Clinical Trials Fund prices

Date Open High Low Close Volume
2024-04-19 $25.59 $25.59 $24.57 $24.71 2 076
2024-04-18 $25.48 $25.48 $25.38 $25.48 233
2024-04-17 $26.25 $26.25 $25.82 $25.82 1 306
2024-04-16 $26.25 $26.25 $26.08 $26.08 3 895
2024-04-15 $26.91 $26.91 $26.31 $26.38 2 781
2024-04-12 $27.42 $27.42 $27.35 $27.35 529
2024-04-11 $27.78 $28.10 $27.64 $28.07 986
2024-04-10 $27.11 $27.34 $27.11 $27.34 689
2024-04-09 $27.57 $27.78 $27.57 $27.68 2 113
2024-04-08 $27.58 $27.58 $27.27 $27.47 680
2024-04-05 $27.25 $27.28 $27.25 $27.28 243
2024-04-04 $28.20 $28.20 $27.04 $27.04 1 571
2024-04-03 $27.57 $27.72 $27.52 $27.67 32 275
2024-04-02 $28.35 $28.35 $27.56 $27.56 1 280
2024-04-01 $28.77 $28.77 $28.31 $28.61 3 940
2024-03-28 $29.24 $29.24 $28.94 $29.13 3 522
2024-03-27 $28.43 $28.99 $28.43 $28.96 3 132
2024-03-26 $28.67 $28.67 $28.40 $28.53 3 172
2024-03-25 $29.02 $29.08 $28.50 $28.50 1 357
2024-03-22 $28.95 $28.95 $28.74 $28.74 2 519
2024-03-21 $29.63 $29.63 $29.26 $29.26 3 011
2024-03-20 $28.49 $29.22 $28.49 $29.09 2 064
2024-03-19 $28.03 $28.84 $28.03 $28.63 5 574
2024-03-18 $29.49 $29.49 $28.25 $28.38 8 925
2024-03-15 $29.11 $29.11 $29.11 $29.11 423
Click to get the best stock tips daily for free!

About BioShares Biotechnology Clinical Trials Fund

The investment seeks investment results that correspond, before fees and expenses, to the price and yield performance of the BioShares Biotechnology Clinical Trials Index. Under normal market conditions, the fund will invest not less than 80% of its total assets in component securities of the index. The index seeks to track the performance of the common stock of U.S. exchange-listed biotechnology companies with a primary product offering ("lead ... BBC Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT